According to 6 analysts, the average rating for BCRX stock is "Buy." The month stock price forecast is $, which is an increase of % from the latest. Today's High. $ Today's Low. $ 52 Week High. $ 52 Week Low. $ RSS News Feeds; Share Page. © BioCryst Pharmaceuticals, Inc. All Rights. View today's BioCryst Pharmaceuticals Inc stock price and latest BCRX news and analysis. Create real-time notifications to follow any changes in the live. BioCryst Pharmaceuticals (BCRX) stock is falling on Thursday after revealing it's no longer developing BCX for competitive reasons. The current stock price of BioCryst Pharmaceuticals (BCRX) is $ as of September 9, What is the market cap of BioCryst Pharmaceuticals (BCRX)?. The.
The 24 analysts offering price forecasts for BioCryst Pharmaceuticals have a median target of , with a high estimate of and a low estimate of Biocryst Pharmaceuticals (BCRX) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. BioCryst Pharmaceuticals Inc BCRX:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/03/24 · 52 Week Low. News for BioCryst Pharmaceuticals Stock (BCRX) · INESSS Recommends Public Reimbursement for BioCryst's ORLADEYO® (berotralstat) for the Prevention of Attacks for. What is the current price for BioCryst Pharma (BCRX)? The stock price for BioCryst Pharma (NASDAQ: BCRX) is $ last updated September 6, at PM. Press Releases ; BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium. Sep 06, ; BioCryst Appoints Dr. Donald Fong Chief Medical. Wall Street Analysts See a % Upside in BioCryst (BCRX): Can the Stock Really Move This High? Jul 18, • Zacks Stocks. BioCryst Pharmaceuticals Price Target Maintained With a $/Share by HC Wainwright & Co. Dow Jones · 08/06 BioCryst. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. BCRX will report earnings. View BioCryst Pharmaceuticals, Inc. BCRX stock quote prices, financial information, real-time forecasts, and company news from CNN. The current price of BCRX is USD — it has decreased by −% in the past 24 hours. Watch BioCryst Pharmaceuticals, Inc. stock price performance more.
(NASDAQ:BCRX - Get Free Report) has received an average recommendation of "Buy" from the seven ratings firms that are presently covering the stock, Marketbeat. BioCryst (BCRX) delivered earnings and revenue surprises of % and %, respectively, for the quarter ended June Do the numbers hold clues to what. In the current month, BCRX has received 11 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. BCRX average Analyst price target in the past 3 months is $ BioCryst Pharmaceuticals Inc. ; Analysts praise EU's Tesla decision, mull Chinese EV startup · TSLAFXPEV ; Stock Market Today: Stocks edge lower with Nvidia. A day after the stock plummeted, it bounced back. Why BioCryst Pharmaceuticals Stock Is Sinking Today. Keith Speights | Feb 21, Investors didn't like. Overview. OPEN. PREV. CLOSE. VOLUME. 1,, MARKET CAP. B · DAY RANGE. – 52 WEEK RANGE. – ; Address. Emperor Blvd. BCRX Biocryst Pharmaceuticals Inc. 35, $ $ (%). Today. Watchers, 35, Wk Low, $ Wk High, $ Market Cap, $B. Wall Street Analysts See a % Upside in BioCryst (BCRX): Can the Stock Really Move This High? Jul 18, • Zacks. BioCryst Pharmaceuticals, Inc.'s stock symbol is BCRX and currently trades under NASDAQ. It's current price per share is approximately $ What are your.
Over the last year, BioCryst Pharmaceuticals shares have traded in a share price range of $ to $ BioCryst Pharmaceuticals currently has ,, Find the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock quote, history, news and other vital information to help you with your stock trading and investing. BioCryst Pharmaceuticals Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range - 52 Wk Range - (NASDAQ: BCRX) Biocryst Pharmaceuticals stock price per share is $ today (as of Aug 30, ). What is Biocryst Pharmaceuticals's Market Cap. Get BioCryst Pharmaceuticals Inc (BCRX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs. View the real-time BCRX price chart on Robinhood and decide if you want to buy or sell commission Low today$ Open price. $ Open price$ Volume. BioCryst Pharmaceuticals Inc. · AT CLOSE PM EDT 09/06/24 · USD · % · Volume1,, BCRX - BioCryst Pharmaceuticals, Inc. (NasdaqGS) - Share Price and News · Overview · Basic Stats · Price Target · Stock Upgrades/Downgrades · Top Investors · Recent. BioCryst Pharmaceuticals Inc. (BCRX) · Financials · Drug Pipeline · Sales Data · Options · Analyst Ratings · Insider Trades · News. BCRX Related stocks ; BCRX, , +% ; ZTS, , +% ; TAK, , +% ; UTHR, , +% ; NBIX, , %. Is BioCryst Pharmaceuticals (NASDAQ:BCRX) a buy? Compare the latest price Current Price: $ 52w High/Low: $ - Market Cap: B. Price.